# A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.

> **NCT02450877** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 7 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** Azacitidine
- **OTHER:** Control Arm

## Key facts

- **NCT ID:** NCT02450877
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-12
- **Primary completion:** 2018-10-10
- **Final completion:** 2019-10-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02450877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02450877, "A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02450877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*